David Windley
Stock Analyst at Jefferies
(4.69)
# 768
Out of 4,534 analysts
810
Total ratings
59%
Success rate
9.4%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Maintained: Buy | $391 → $450 | $382.23 | +17.73% | 78 | Jul 16, 2026 | |
| MEDP Medpace Holdings | Downgraded: Hold | $490 → $515 | $527.93 | -2.45% | 35 | Jul 7, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Buy | $135 → $193 | $166.18 | +16.14% | 74 | Jun 25, 2026 | |
| CRL Charles River Laboratories International | Maintained: Buy | $225 | $219.70 | +2.41% | 75 | May 8, 2026 | |
| CNC Centene | Maintained: Hold | $43 → $39 | $65.84 | -40.77% | 88 | Apr 20, 2026 | |
| CI The Cigna Group | Maintained: Buy | $336 → $330 | $283.94 | +16.22% | 64 | Apr 20, 2026 | |
| MOH Molina Healthcare | Maintained: Hold | $160 → $139 | $229.71 | -39.49% | 60 | Apr 20, 2026 | |
| UNH UnitedHealth Group | Maintained: Buy | $340 → $373 | $421.55 | -11.52% | 73 | Apr 20, 2026 | |
| OSCR Oscar Health | Upgraded: Hold | $12 → $16 | $29.60 | -45.95% | 7 | Apr 20, 2026 | |
| HUM Humana | Maintained: Buy | $235 | $398.20 | -40.98% | 68 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $365 → $295 | $352.32 | -16.27% | 42 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $18 | $19.15 | -8.62% | 15 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 → $255 | $203.90 | +25.06% | 59 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $20 | $17.42 | +11.94% | 14 | Nov 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $9.5 | $17.73 | -46.42% | 3 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $3 | $0.7117 | +321.53% | 2 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $263 | $214.47 | n/a | 2 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $2.5 | $0.0111 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $335 | $197.41 | n/a | 8 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $16 → $15 | $6.94 | n/a | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $177 → $190 | $44.56 | n/a | 3 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $200 → $248 | $9.65 | n/a | 5 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8.5 | $4.80 | n/a | 10 | Aug 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $5.93 | n/a | 4 | Aug 21, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $129 | $362.78 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9.5 | $1.42 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $36 | $3.32 | n/a | 1 | Dec 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $68 | $182.10 | n/a | 1 | Nov 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $51.72 | n/a | 1 | Aug 27, 2009 |
Elevance Health
Jul 16, 2026
Maintained: Buy
Price Target: $391 → $450
Current: $382.23
Upside: +17.73%
Medpace Holdings
Jul 7, 2026
Downgraded: Hold
Price Target: $490 → $515
Current: $527.93
Upside: -2.45%
ICON Public Limited Company
Jun 25, 2026
Reiterated: Buy
Price Target: $135 → $193
Current: $166.18
Upside: +16.14%
Charles River Laboratories International
May 8, 2026
Maintained: Buy
Price Target: $225
Current: $219.70
Upside: +2.41%
Centene
Apr 20, 2026
Maintained: Hold
Price Target: $43 → $39
Current: $65.84
Upside: -40.77%
The Cigna Group
Apr 20, 2026
Maintained: Buy
Price Target: $336 → $330
Current: $283.94
Upside: +16.22%
Molina Healthcare
Apr 20, 2026
Maintained: Hold
Price Target: $160 → $139
Current: $229.71
Upside: -39.49%
UnitedHealth Group
Apr 20, 2026
Maintained: Buy
Price Target: $340 → $373
Current: $421.55
Upside: -11.52%
Oscar Health
Apr 20, 2026
Upgraded: Hold
Price Target: $12 → $16
Current: $29.60
Upside: -45.95%
Humana
Feb 27, 2026
Maintained: Buy
Price Target: $235
Current: $398.20
Upside: -40.98%
Feb 10, 2026
Maintained: Buy
Price Target: $365 → $295
Current: $352.32
Upside: -16.27%
Feb 10, 2026
Maintained: Hold
Price Target: $21 → $18
Current: $19.15
Upside: -8.62%
Feb 6, 2026
Maintained: Buy
Price Target: $225 → $255
Current: $203.90
Upside: +25.06%
Nov 20, 2025
Maintained: Buy
Price Target: $16 → $20
Current: $17.42
Upside: +11.94%
Sep 8, 2025
Maintained: Hold
Price Target: $21 → $9.5
Current: $17.73
Upside: -46.42%
Aug 25, 2025
Maintained: Hold
Price Target: $2.75 → $3
Current: $0.7117
Upside: +321.53%
Jun 4, 2025
Maintained: Hold
Price Target: $263
Current: $214.47
Upside: n/a
Jun 2, 2025
Maintained: Hold
Price Target: $1.5 → $2.5
Current: $0.0111
Upside: n/a
Jun 2, 2025
Maintained: Buy
Price Target: $280 → $335
Current: $197.41
Upside: n/a
Apr 21, 2025
Maintained: Hold
Price Target: $16 → $15
Current: $6.94
Upside: n/a
Apr 26, 2021
Maintained: Buy
Price Target: $177 → $190
Current: $44.56
Upside: n/a
Feb 25, 2021
Maintained: Hold
Price Target: $200 → $248
Current: $9.65
Upside: n/a
Aug 4, 2020
Rated: Hold
Price Target: $7 → $8.5
Current: $4.80
Upside: n/a
Aug 21, 2017
Reiterated: Buy
Price Target: $28
Current: $5.93
Upside: n/a
Dec 2, 2016
Reiterated: Buy
Price Target: $129
Current: $362.78
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $9.5
Current: $1.42
Upside: n/a
Dec 2, 2016
Reiterated: Hold
Price Target: $36
Current: $3.32
Upside: n/a
Nov 28, 2016
Reiterated: Hold
Price Target: $68
Current: $182.10
Upside: n/a
Aug 27, 2009
Downgraded: Hold
Price Target: $12
Current: $51.72
Upside: n/a